| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 28, 225-237, Copyright © 1987 by Lipid Research, Inc.
REVIEWS |
CH Sloop, L Dory and PS Roheim
While a wide variety of techniques has been used to collect samples of interstitial fluid, most of our detailed knowledge about the composition of interstitial fluid lipoproteins has come from lymph collection studies. The considerable variability of lymph data probably reflects the effect of variable metabolic modification and different capillary permeabilities on the lipoprotein composition of interstitial fluid. All density classes of plasma lipoproteins are present in lymph. In peripheral lymph, the lymph/plasma concentration ratios of lipoproteins vary from 0.03 for VLDL-sized particles to 0.2 for HDL. Lymph from more permeable vascular beds, such as lung and myocardium, contains proportionately more lipoproteins. Their lymph/plasma concentration ratios vary from 0.1 to 0.6. In general, lymph lipoproteins are more heterogeneous in size than their plasma counterparts. Lymph HDL and LDL contain larger and smaller particles than their plasma equivalents. Lymph lipoproteins have unusual shapes (square packing and discoidal), chemical compositions, and molecular charge, which suggest de novo formation and/or extensive peripheral modification. Lymph HDL and LDL are enriched in free cholesterol. Lymph HDL also has increased cholesterol/protein and phospholipid/protein (especially sphingomyelin) ratios (Sloop, C.H., L. Dory, and P.S. Roheim, unpublished observations). Lymph HDL apoprotein composition differs from that of plasma, with an increase in apoE and apoA-IV content relative to apoA-I. These discoidal HDL particles may be products of an initial stage of reverse cholesterol transport. We believe further study of their metabolic fate would give important information concerning the later stages of reverse cholesterol transport.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Kawamura, D. Baitsch, R. Telgmann, R. Feuerborn, G. Weissen-Plenz, C. Hagedorn, K. Saku, S.-M. Brand-Herrmann, A. von Eckardstein, G. Assmann, et al. Apolipoprotein E Interrupts Interleukin-1{beta} Signaling in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1610 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pappu, S. R. Schwab, I. Cornelissen, J. P. Pereira, J. B. Regard, Y. Xu, E. Camerer, Y.-W. Zheng, Y. Huang, J. G. Cyster, et al. Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate Science, April 13, 2007; 316(5822): 295 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-D. Wang, R. S. Kiss, V. Franklin, H. M. McBride, S. C. Whitman, and Y. L. Marcel Different cellular traffic of LDL-cholesterol and acetylated LDL-cholesterol leads to distinct reverse cholesterol transport pathways J. Lipid Res., March 1, 2007; 48(3): 633 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Thaveeratitham, W. Plengpanich, W. Naen-Udorn, S. Patumraj, and W. Khovidhunkit Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endothelial cells in vivo and on the growth of Escherichia coli in vitro Innate Immunity, February 1, 2007; 13(1): 58 - 64. [Abstract] [PDF]
|
|
|
|
|
|
A. Nilsson and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J. Lipid Res., January 1, 2006; 47(1): 154 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Favari, M. Lee, L. Calabresi, G. Franceschini, F. Zimetti, F. Bernini, and P. T. Kovanen Depletion of Pre-{beta}-high Density Lipoprotein by Human Chymase Impairs ATP-binding Cassette Transporter A1- but Not Scavenger Receptor Class B Type I-mediated Lipid Efflux to High Density Lipoprotein J. Biol. Chem., March 12, 2004; 279(11): 9930 - 9936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Thorngate, P. G. Yancey, G. Kellner-Weibel, L. L. Rudel, G. H. Rothblat, and D. L. Williams Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression J. Lipid Res., December 1, 2003; 44(12): 2331 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Desrumaux, P. A. Mak, W. A. Boisvert, D. Masson, D. Stupack, M. Jauhiainen, C. Ehnholm, and L. K. Curtiss Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells J. Lipid Res., August 1, 2003; 44(8): 1453 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Siegel, C. Abletshauser, M. Malmsten, A. Schmidt, and K. Winkler Reduction of arteriosclerotic nanoplaque formation and size by fluvastatin in a receptor-based biosensor model Cardiovasc Res, June 1, 2003; 58(3): 696 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Tannock, K. L. Olin, P. H. R. Barrett, T. N. Wight, and A. Chait Triglyceride-Rich Lipoproteins from Subjects with Type 2 Diabetes Do Not Demonstrate Increased Binding to Biglycan, a Vascular Proteoglycan J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 35 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Nanjee, C. J. Cooke, J. S. Wong, R. L. Hamilton, W. L. Olszewski, and N. E. Miller Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids J. Lipid Res., April 1, 2001; 42(4): 639 - 648. [Abstract] [Full Text]
|
|
|
|
|
|
M. N. Nanjee, C. J. Cooke, W. L. Olszewski, and N. E. Miller Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans: associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency J. Lipid Res., August 1, 2000; 41(8): 1317 - 1327. [Abstract] [Full Text]
|
|
|
|
|
|
N. Fournier, V. Atger, J.-L. Paul, M. Sturm, N. Duverger, G. H. Rothblat, and N. Moatti Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1283 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Fagan, D. M. Holtzman, G. Munson, T. Mathur, D. Schneider, L. K. Chang, G. S. Getz, C. A. Reardon, J. Lukens, J. A. Shah, et al. Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (-/-), and Human apoE Transgenic Mice J. Biol. Chem., October 15, 1999; 274(42): 30001 - 30007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Rothblat, M. de la Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips Cell cholesterol efflux: integration of old and new observations provides new insights J. Lipid Res., May 1, 1999; 40(5): 781 - 796. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Kawai, D. Mathew, C. Tanaka, and M. Rowland Physiologically Based Pharmacokinetics of Cyclosporine A: Extension to Tissue Distribution Kinetics in Rats and Scale-up to Human J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 457 - 468. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Benvenga and J. Robbins Thyroid Hormone Efflux from Monolayer Cultures of Human Fibroblasts and Hepatocytes. Effect of Lipoproteins and Other Thyroxine Transport Proteins Endocrinology, October 1, 1998; 139(10): 4311 - 4318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Asztalos, W. Zhang, P. S. Roheim, and L. Wong Role of Free Apolipoprotein A-I in Cholesterol Efflux : Formation of Pre–{alpha}-Migrating High-Density Lipoprotein Particles Arterioscler. Thromb. Vasc. Biol., September 1, 1997; 17(9): 1630 - 1636. [Abstract] [Full Text]
|
|
|
|
|
|
B. Jaspard, N. Fournier, G. Vieitez, V. Atger, R. Barbaras, C. Vieu, J. Manent, H. Chap, B. Perret, and X. Collet Structural and Functional Comparison of HDL From Homologous Human Plasma and Follicular Fluid : A Model for Extravascular Fluid Arterioscler. Thromb. Vasc. Biol., August 1, 1997; 17(8): 1605 - 1613. [Abstract] [Full Text]
|
|
|
|
|
|
W. V. Rodrigueza, K. J. Williams, G. H. Rothblat, and M. C. Phillips Remodeling and Shuttling: Mechanisms for the Synergistic Effects Between Different Acceptor Particles in the Mobilization of Cellular Cholesterol Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 383 - 393. [Abstract] [Full Text]
|
|
|
|
|
|
B. F. Asztalos and P. S. Roheim Presence and Formation of `Free Apolipoprotein A-I–Like' Particles in Human Plasma Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1419 - 1423. [Abstract] [Full Text]
|
|
|
|
|
|
C. Warden, C. Hedrick, J. Qiao, L. Castellani, and A. Lusis Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II Science, July 23, 1993; 261(5120): 469 - 472. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
